ArticleMolecular and cellular biochemistry2011

Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer.

Fabrice Pierre et al.PubMed ↗Publisher ↗

No numbers read from the abstract.